Cargando…
BCR‐ABL1 transcript levels at 4 weeks have prognostic significance for time‐specific responses and for predicting survival in chronic‐phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors
The present study aimed to assess the clinical impact of BCR‐ABL1 transcript levels determined at an earlier time point than the 3‐month early molecular response (EMR) in chronic‐phase chronic myeloid leukemia (CML‐CP) patients. BCR‐ABL1 transcript levels of CML‐CP patients (n = 258; median age, 43...
Autores principales: | Song, Hye‐young, Noh, Hayeon, Choi, Soo young, Lee, Sung‐Eun, Kim, Soo‐Hyun, Kee, Kyung‐Mi, Yoo, Hea‐Lyun, Lee, Mi‐young, Kang, Ki‐Hoon, Suh, Ji‐Hyung, Yang, Seon‐young, Jang, Eun‐Jung, Lee, Jangik I., Kim, Dong‐Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198233/ https://www.ncbi.nlm.nih.gov/pubmed/30171671 http://dx.doi.org/10.1002/cam4.1753 |
Ejemplares similares
-
BCR-ABL1 transcripts (MR(4.5)) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia
por: Lee, Sung-Eun, et al.
Publicado: (2017) -
Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis
por: Jung, Su Young, et al.
Publicado: (2017) -
Discontinuation of tyrosine kinase inhibitors based on BCR-ABL1 monitoring by digital droplet PCR in pediatric chronic myeloid leukemia
por: Kim, Yeojae, et al.
Publicado: (2022) -
Diagnostic Usefulness of the Janus Kinase 2 Mutation in non BCR/ABL Myeloproliferative Disorders
por: Bang, Soo-Mee, et al.
Publicado: (2006) -
Promyelocytic Blast Phase of Chronic Myeloid Leukemia, BCR-ABL1-Positive: Points to be Considered at Diagnosis
por: Kim, Bohyun, et al.
Publicado: (2021)